Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Seurat Therapeutics

Seurat Therapeutics?uq=WouuG6Ev
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$773K LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a therapeutics company intended to offer migraine care. The company's medication stimulates the brain and improves its health by environmental enrichment which can reduce brain disease by half through replicating the naturally occurring phenomenon in a therapeutic approach, enabling patients to recover from migraine attacks fast by more effective medication.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • 1452 East 53rd Street
  • 2nd Floor
  • Chicago, IL 60615
  • United States

+1 (312) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Seurat Therapeutics’s full profile, request a free trial.

Seurat Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 21-Feb-2018 $773K 00000 Completed Startup
1. Accelerator/Incubator 05-Oct-2017 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Seurat Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Polsky Center Accelerator/Incubator Minority 000 0000 000000 0

Seurat Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Yuan Zhang Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Sharon Lew Chief Financial Officer
Richard Kraig Ph.D Co-Founder & Chief Scientific Officer
Martin Sanders MD Co-Founder & Chairman

Seurat Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
Martin Sanders MD Seurat Therapeutics Co-Founder & Chairman 000 0000
Yuan Zhang Ph.D Seurat Therapeutics Co-Founder, President, Chief Executive Officer & Board Member 000 0000